SCHEMBL17300243

SCHEMBL17300243

O=P(c1ccccc1)(c1ccccc1)c1ccc2c(c1)nc(-c1ccccc1)c1c3ccccc3c3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 9/20 0.36
PDE10A Q9Y233 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DHFR P00374 1/20 0.33
ADORA2A P29274 1/20 0.33
NUDT1 P36639 1/20 0.33
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17300236 0.93 DHODH (0.38) DHODHPDE10ALMNATSHRKDM4E
SCHEMBL17300241 0.93 DHFR (0.40) DHODHPDE10ALMNATSHRCSNK2A2
SCHEMBL23861266 0.91 TOP1 (0.40) DHODHCSNK2A2CSNK2BADORA2A
SCHEMBL17300246 0.91 DHFR (0.39) DHODHPDE10ALMNACSNK2A2CSNK2B
SCHEMBL17300237 0.90 DHODH (0.40) DHODHPDE10ALMNATSHRKDM4E
SCHEMBL17300231 0.89 DHODH (0.42) DHODHPDE10ALMNATSHRALDH1A1
SCHEMBL17914731 0.89 DHODH (0.42) DHODHPDE10ALMNATSHRALDH1A1
SCHEMBL19051799 0.88 TOP1 (0.35) DHODHCSNK2A2CSNK2BALDH1A1KDM4E
SCHEMBL19051804 0.88 TOP1 (0.35) DHODHCSNK2A2CSNK2BALDH1A1KDM4E
SCHEMBL17914776 0.88 DHODH (0.41) DHODHPDE10ALMNATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608189-B2 Condensed cyclic compounds and organic light-emitting devices including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-31 US disclosed
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10608189-B2 Condensed cyclic compounds and organic light-emitting devices including the same CRY1, CRY2, CCNE2 DHODH 1979/4885PDE10A 2631/4885LMNA 1284/4885
US-20170179407-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 DHODH 1619/4885PDE10A 2487/4885LMNA 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.